These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10994625)

  • 1. Retrovirus-mediated in vivo gene therapy using the herpes simplex virus thymidine kinase gene against carcinomatous peritonitis.
    Toyokawa Y; Kuriyama S; Tsujinoue H; Nakatani T; Mitoro A; Yoshiji H; Fukui H
    Scand J Gastroenterol; 2000 Aug; 35(8):852-60. PubMed ID: 10994625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
    Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
    Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
    Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer.
    Yee D; McGuire SE; Brünner N; Kozelsky TW; Allred DC; Chen SH; Woo SL
    Hum Gene Ther; 1996 Jun; 7(10):1251-7. PubMed ID: 8793549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y; Zhang X; Hui H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
    Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
    Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng ; An W; Dai J
    Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined suicide and cytokine gene therapy for peritoneal carcinomatosis.
    Lechanteur C; Delvenne P; Princen F; Lopez M; Fillet G; Gielen J; Merville MP; Bours V
    Gut; 2000 Sep; 47(3):343-8. PubMed ID: 10940269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
    Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D
    Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene.
    Aoki K; Yoshida T; Matsumoto N; Ide H; Hosokawa K; Sugimura T; Terada M
    Hum Gene Ther; 1997 Jun; 8(9):1105-13. PubMed ID: 9189768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells.
    Freeman SM; Ramesh R; Shastri M; Munshi A; Jensen AK; Marrogi AJ
    Cancer Lett; 1995 Jun; 92(2):167-74. PubMed ID: 7600527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene.
    Kuriyama S; Masui K; Kikukawa M; Sakamoto T; Nakatani T; Nagao S; Yamazaki M; Yoshiji H; Tsujinoue H; Fukui H; Yoshimatsu T; Ikenaka K
    Gene Ther; 1999 Apr; 6(4):525-33. PubMed ID: 10476212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
    Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
    Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
    Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
    J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.